Literature DB >> 9468159

Diagnostic accuracy of protected specimen brush and bronchoalveolar lavage in nosocomial pneumonia: impact of previous antimicrobial treatments.

B Souweine1, B Veber, J P Bedos, B Gachot, M C Dombret, B Regnier, M Wolff.   

Abstract

OBJECTIVE: To determine whether the diagnostic accuracy of bronchoscopy samples in patients with suspected ventilator-associated pneumonia is affected by prior antibiotic treatment given for a previous infection, and/or by antibiotic treatment recently started to treat suspected ventilator-associated pneumonia.
DESIGN: Study of critically ill patients.
SETTING: Intensive care unit in a university hospital. PATIENTS: Sixty-three episodes of suspected ventilator-associated pneumonia were prospectively evaluated. Based on prior antibiotic treatment, three groups were defined: no antibiotic group (no previous antibiotic treatments), n = 12; current antibiotic group (antibiotic treatment initiated >72 hrs earlier), n = 31; and recent antibiotic group (new antibiotic treatment class started within the last 24 hrs), n = 20.
INTERVENTIONS: Fiberoptic bronchoscopy with quantitative protected specimen brush cultures, bronchoalveolar lavage cultures, and intracellular organism counts of bronchoalveolar lavage cells.
MEASUREMENTS AND MAIN RESULTS: The diagnosis of ventilator-associated pneumonia was made in 35 cases, based on histology (n = 2), cavitation (n = 2), blood cultures (n = 4), or outcome under appropriate antibiotic treatment (n = 27). The discriminative value of the tests, based on the area under the receiver operating characteristic curve, was high (> or =0.85) in both current antibiotic treatment and recent antibiotic treatment patients. Sensitivities for a 5% intracellular organism count of bronchoalveolar lavage cells, a protected specimen brush culture threshold of 10(3) colony-forming units (cfu)/mL, and a bronchoalveolar lavage culture threshold of 10(5) cfu/mL were as follows, respectively, in the three groups: 0.71, 0.88, and 0.71 (no antibiotic treatment group); 0.5, 0.77, and 0.83 (current antibiotic group); and 0.67, 0.40, and 0.38 (recent antibiotic group). Specificity was consistently > or =0.9. In the recent antibiotic group, protected specimen brush and bronchoalveolar lavage cultures had lower sensitivities (p < .05), and the best threshold values for these two tests were 10(2) cfu/mL and 10(3) cfu/mL, respectively.
CONCLUSIONS: After recent introduction of an antibiotic treatment for suspected ventilator-associated pneumonia, protected specimen brush and bronchoalveolar lavage culture thresholds must be decreased to maintain good accuracy. In contrast, current antibiotic treatment prescribed for a prior infectious disease does not modify the diagnostic accuracy of protected specimen brush or bronchoalveolar lavage.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9468159     DOI: 10.1097/00003246-199802000-00017

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  39 in total

Review 1.  Acute respiratory distress syndrome and nosocomial pneumonia.

Authors:  T T Bauer; A Torres
Journal:  Thorax       Date:  1999-11       Impact factor: 9.139

2.  Outcome of postoperative pneumonia in the Eole study.

Authors:  Hervé Dupont; Philippe Montravers; Rémy Gauzit; Benoît Veber; Jean-Louis Pouriat; Claude Martin
Journal:  Intensive Care Med       Date:  2003-01-14       Impact factor: 17.440

3.  Pulmonary Infections in Ventilated Patients: Diagnostic and Therapeutic Options.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-06       Impact factor: 3.725

4.  Direct examination and cultures of bronchoalveolar lavage in pneumonia diagnosis: a comparative experimental study.

Authors:  Nilton Brandão da Silva; Lucas Martins; Frederico Martins; José Anflor; Tiago Tonietto; Cristiano Koefender; Paulo G Cardoso; José Moreira
Journal:  Intensive Care Med       Date:  2007-08-03       Impact factor: 17.440

5.  Ventilator-associated pneumonia: diagnosis, treatment, and prevention.

Authors:  Steven M Koenig; Jonathon D Truwit
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

6.  Bronchoalveolar lavage for VAP diagnosis: patients must be sampled before any change of antimicrobial therapy.

Authors:  Jean-François Timsit
Journal:  Intensive Care Med       Date:  2007-08-03       Impact factor: 17.440

7.  Defining, treating and preventing hospital acquired pneumonia: European perspective.

Authors:  Antoni Torres; Santiago Ewig; Harmut Lode; Jean Carlet
Journal:  Intensive Care Med       Date:  2008-11-07       Impact factor: 17.440

8.  Topographical continuity of bacterial populations in the healthy human respiratory tract.

Authors:  Emily S Charlson; Kyle Bittinger; Andrew R Haas; Ayannah S Fitzgerald; Ian Frank; Anjana Yadav; Frederic D Bushman; Ronald G Collman
Journal:  Am J Respir Crit Care Med       Date:  2011-06-16       Impact factor: 21.405

9.  Efficacy of adequate early antibiotic therapy in ventilator-associated pneumonia: influence of disease severity.

Authors:  Christophe Clec'h; Jean-François Timsit; Arnaud De Lassence; Elie Azoulay; Corinne Alberti; Maite Garrouste-Orgeas; Bruno Mourvilier; Gilles Troche; Muriel Tafflet; Olivier Tuil; Yves Cohen
Journal:  Intensive Care Med       Date:  2004-06-09       Impact factor: 17.440

10.  Variation of infected cell count in bronchoalveolar lavage and timing of ventilator-associated pneumonia.

Authors:  Hervé Dupont; Viviane Chalhoub; Gaëtan Plantefève; Cyrille De Vaumas; Nathalie Kermarrec; Catherine Paugam-Burtz; Jean Mantz
Journal:  Intensive Care Med       Date:  2004-05-13       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.